发明申请
US20140031331A1 AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY
有权
氨基嘌呤衍生物，含有它们的药物组合物及其在治疗中的使用
- 专利标题： AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY
- 专利标题（中）： 氨基嘌呤衍生物，含有它们的药物组合物及其在治疗中的使用
-
申请号： US14031265申请日： 2013-09-19
-
公开(公告)号： US20140031331A1公开(公告)日： 2014-01-30
- 发明人: Wilhelm Amberg , Michael Ochse , Udo Lange , Andreas Kling , Berthold Behl , Wilfried Hornberger , Mario Mezler , Charles W. Hutchins
- 申请人： ABBOTT LABORATORIES , ABBVIE DEUTSCHLAND GMBH & CO KG
- 主分类号： C07C311/05
- IPC分类号： C07C311/05 ; C07D233/84 ; C07D231/18 ; C07D213/71 ; C07D409/12 ; C07D207/12 ; C07D275/02 ; C07D205/04 ; C07D403/12 ; C07D401/12 ; C07C271/24 ; C07D333/34
摘要：
The present invention relates to aminotetraline derivatives of the formula (I) or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such aminotetraline derivatives, and the use of such aminotetraline derivatives for therapeutic purposes. The aminotetraline derivatives are GlyT1 inhibitors.
公开/授权文献
信息查询
